Immune cellular parameters of leprosy and human immunodeficiency virus‐1 co‐infected subjects

Leprosy and human immunodeficiency virus‐1 (HIV‐1) are examples of human infections where interactions between the pathogen and the host cellular immunity determine the clinical manifestations of disease. Hence, a significant immunopathological interaction between HIV‐1 and leprosy might be expected. In the present study we explored several aspects of cellular immunity in patients co‐infected with HIV‐1 and Mycobacterium leprae. Twenty‐eight individuals were studied, comprising four groups: healthy controls, HIV‐1 and M. leprae co‐infection, HIV‐1 mono‐infection, and M. leprae mono‐infection. Subjects in the mono‐infection and co‐infection groups were matched as far as possible for bacillary load and HIV disease status, as appropriate. Peripheral blood mononuclear cells (PBMC) were analysed using six‐ and seven‐colour flow cytometry to evaluate T‐cell subpopulations and their activation status, dendritic cell (DC) distribution phenotypes and expression of IL‐4 by T cells. The co‐infected group exhibited lower CD4 : CD8 ratios, higher levels of CD8+ T‐cell activation, increased Vδ1 : Vδ2 T cell ratios and decreased percentages of plasmacytoid DC, compared with HIV‐1 mono‐infected subjects. Across infected groups, IL‐4 production by CD4+ T lymphocytes was positively correlated with the percentage of effector memory CD4+ T cells, suggesting antigenically driven differentiation of this population of T cells in both HIV‐1 and M. leprae infections. Co‐infection with M. leprae may exacerbate the immunopathology of HIV‐1 disease. A T helper 2 (Th2) bias in the CD4+ T‐cell response was evident in both HIV‐1 infection and leprosy, but no additive effect was apparent in co‐infected patients.

[1]  S. Lawn,et al.  Interactions between HIV infection and leprosy: a paradox. , 2006, The Lancet. Infectious diseases.

[2]  A. Sher,et al.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis , 2005, The Journal of experimental medicine.

[3]  R. Salomão,et al.  Interferon‐γ and tumour necrosis factor‐α production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis , 2005 .

[4]  F. Goebel Immune Reconstitution Inflammatory Syndrome (IRIS)—Another New Disease Entity Following Treatment Initiation of HIV Infection , 2005, Infection.

[5]  A. Stütz,et al.  CD45 isoform expression is associated with different susceptibilities of human naive and effector CD4+ T cells to respond to IL‐4 , 2005, European journal of immunology.

[6]  M. M. Stefani,et al.  Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. , 2004, The American journal of tropical medicine and hygiene.

[7]  P. Couppié,et al.  Immune reconstitution inflammatory syndrome associated with HIV and leprosy. , 2004, Archives of dermatology.

[8]  E. Sampaio,et al.  Patterns of intracellular cytokines in CD4 and CD8 T cells from patients with mycobacterial infections. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[9]  J. Habbema,et al.  The future incidence of leprosy: a scenario analysis. , 2004, Bulletin of the World Health Organization.

[10]  M. Battegay,et al.  Immune reconstitution in HIV-infected patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[12]  D. Ho,et al.  Human Immunodeficiency Virus Type 1 Induces Persistent Changes in Mucosal and Blood γδ T Cells despite Suppressive Therapy , 2003, Journal of Virology.

[13]  J. Levy,et al.  Protection from HIV/AIDS: the importance of innate immunity. , 2003, Clinical immunology.

[14]  J. Wiesner,et al.  Microbial isoprenoid biosynthesis and human γδ T cell activation , 2003, FEBS letters.

[15]  S. Akira,et al.  Activation and regulation of Toll-like receptors 2 and 1 in human leprosy , 2003, Nature Medicine.

[16]  C. Agrati,et al.  Innate T-Cell Immunity in HIV Infections: The Role of Vg9Vd2 T Lymphocytes , 2002 .

[17]  R. Salomão,et al.  Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease , 2002, Clinical and experimental immunology.

[18]  M Roederer,et al.  Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. , 2001, Cytometry.

[19]  N. Kadowaki,et al.  Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.

[20]  D. Hom,et al.  Impact of tuberculosis (TB) on HIV‐1 activity in dually infected patients , 2001, Clinical and experimental immunology.

[21]  V. Ramesh,et al.  The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients. , 2000, Immunology letters.

[22]  F. Antunes,et al.  Bulk cytokine production versus frequency of cytokine-producing cells in HIV1 infection before and during HAART. , 2000, Clinical immunology.

[23]  B. Gormus,et al.  Interactions between Mycobacterium leprae and simian immunodeficiency virus (SIV) in rhesus monkeys , 2000, Journal of medical primatology.

[24]  M. Roederer,et al.  Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. , 1999, International immunology.

[25]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[26]  J. Treanor,et al.  Detection of intracellular antigen-specific cytokines in human T cell populations. , 1999, The Journal of infectious diseases.

[27]  R. Modlin,et al.  T cell mediated immunity to Mycobacterium tuberculosis. , 1999, Current opinion in microbiology.

[28]  L. Cosmi,et al.  Enhanced HIV expression during Th2‐oriented responses explained by the opposite regulatory effect of IL‐4 and IFN‐γ on fusin/CXCR4 , 1998, European journal of immunology.

[29]  G. Kaplan,et al.  Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals , 1995, Infection and immunity.

[30]  R L Modlin,et al.  Th1-Th2 paradigm: insights from leprosy. , 1994, The Journal of investigative dermatology.

[31]  J. Abrams,et al.  Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. , 1993, Journal of immunology.

[32]  J. Abrams,et al.  Patterns of cytokine production by mycobacterium-reactive human T-cell clones , 1993, Infection and immunity.

[33]  B. Bloom,et al.  Cytokine patterns of immunologically mediated tissue damage. , 1992, Journal of immunology.

[34]  J. Abrams,et al.  γδ T Lymphocytes in Human Tuberculosis , 1992 .

[35]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[36]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[37]  B. Bloom Learning from leprosy: a perspective on immunology and the Third World. , 1986, Journal of immunology.

[38]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[39]  Singh Rp Treatment of leprosy. , 1966, Indian journal of dermatology.

[40]  Ridley Ds,et al.  Classification of leprosy according to immunity. A five-group system. , 1966 .

[41]  Dharmendra.,et al.  Classification of leprosy. , 1948, Indian journal of venereal diseases and dermatology.

[42]  R. Salomão,et al.  Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis. , 2005, Clinical and experimental immunology.

[43]  A. Sher,et al.  TLR 9 regulates Th 1 responses and cooperates with TLR 2 in mediating optimal resistance to Mycobacterium tuberculosis , 2005 .

[44]  B. Pulendran Modulating Th1/Th2 responses with microbes, dendritic cells, and pathogen recognition receptors , 2004, Immunologic research.

[45]  D. Ho,et al.  Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. , 2003, Journal of virology.

[46]  C. Agrati,et al.  Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes. , 2002, Current molecular medicine.

[47]  B. M. D. S. C. N. D. D. E. Aids Recomendacoes para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV - 2000 , 2000 .

[48]  D. Hom,et al.  Accelerated course of human immunodeficiency virus infection after tuberculosis. , 1995, American journal of respiratory and critical care medicine.

[49]  S. Imamura,et al.  Appearance of gamma delta T cell receptor-positive cells following alpha beta T cell receptor-positive cells in the lepromin reaction of human skin. , 1993, Immunology letters.

[50]  S. Imamura,et al.  Appearance of γδ T cell receptor-positive cells following αβ T cell receptor-positive cells in the lepromin reaction of human skin , 1993 .

[51]  J. Abrams,et al.  Gamma delta T lymphocytes in human tuberculosis. , 1992, The Journal of infectious diseases.

[52]  D. Ridley,et al.  Classification of leprosy according to immunity. A five-group system. , 1966, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[53]  F. P. Merklen [Microbial antigens]. , 1958, La Revue du praticien.